148 related articles for article (PubMed ID: 28129655)
1. A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma.
Shao Y; Zhang Y; Hou Y; Tong H; Zhuang R; Ji Z; Wang B; Zhou Y; Lu W
Oncotarget; 2017 Feb; 8(8):13971-13978. PubMed ID: 28129655
[TBL] [Abstract][Full Text] [Related]
2. Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3.
Zhang Y; Tong H; He J; Shao Y; Guo X; Zhuang R; Yang J; Liu J; Ding Y; Liu W; Lu W; Zhou Y
Cell Death Dis; 2019 Jun; 10(6):430. PubMed ID: 31160581
[TBL] [Abstract][Full Text] [Related]
3. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
4. Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.
Butò S; Pierotti MA; Tamborini E; Della Torre G; Lavarino C; Rilke F; Pilotti S
Diagn Mol Pathol; 1999 Sep; 8(3):125-30. PubMed ID: 10565683
[TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal lipomatous angiomyolipoma associated with amyloid deposition masquerading as well-differentiated liposarcoma.
Shimada S; Harada H; Ishizawa K; Hirose T
Pathol Int; 2006 Oct; 56(10):638-41. PubMed ID: 16984623
[TBL] [Abstract][Full Text] [Related]
6. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
8. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.
Shimada S; Ishizawa T; Ishizawa K; Kamada K; Hirose T
Virchows Arch; 2005 Nov; 447(5):835-41. PubMed ID: 16012847
[TBL] [Abstract][Full Text] [Related]
10. Distinct MDM2 and P14ARF expression and centrosome amplification in well-differentiated liposarcomas.
Perucca-Lostanlen D; Rostagno P; Grosgeorge J; Marcié S; Gaudray P; Turc-Carel C
Genes Chromosomes Cancer; 2004 Feb; 39(2):99-109. PubMed ID: 14695989
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
12. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
13. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
Boltze C; Schneider-Stock R; Jäger V; Roessner A
Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
[TBL] [Abstract][Full Text] [Related]
14. alpha-fetoprotein expression in a dedifferentiated liposarcoma.
Bosco M; Allia E; Coindre JM; Odasso C; Pagani A; Pacchioni D
Virchows Arch; 2006 Apr; 448(4):517-20. PubMed ID: 16489442
[TBL] [Abstract][Full Text] [Related]
15. MDM2-positive papillary sarcomatoid renal cell carcinoma: a potential diagnostic pitfall.
Jeruc J; Čugura T; Tomažič A; Boštjančič E
Virchows Arch; 2020 May; 476(5):783-786. PubMed ID: 31732813
[TBL] [Abstract][Full Text] [Related]
16. Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence.
Zhang S; Yan L; Cui C; Wang Z; Wu J; Zhao M; Dong B; Guan X; Tian X; Hao C
Oncol Rep; 2020 Aug; 44(2):565-576. PubMed ID: 32627015
[TBL] [Abstract][Full Text] [Related]
17. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.
Mariani O; Brennetot C; Coindre JM; Gruel N; Ganem C; Delattre O; Stern MH; Aurias A
Cancer Cell; 2007 Apr; 11(4):361-74. PubMed ID: 17418412
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma.
Kiguchi K; Ishiwata I; Ishiwata E; Koshitaka Y; Ohara T; Okudai Y; Sato S; Kobayashi Y; Ishizuka B; Ishikawa H
Hum Cell; 2005 Mar; 18(1):45-52. PubMed ID: 16130899
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular genetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Macarenco RS; Erickson-Johnson M; Wang X; Jenkins RB; Nascimento AG; Oliveira AM
Cancer Genet Cytogenet; 2006 Dec; 171(2):126-9. PubMed ID: 17116493
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and amplification of Murine double minute 2 as a diagnostic tool in large lipomatous tumor and its correlation with Ki67 proliferation index: an institutional experience.
Putri RI; Siregar NC; Siregar B
Indian J Pathol Microbiol; 2014; 57(4):558-63. PubMed ID: 25308007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
